483
Julio WainsteinJulio Wainstein – FDA 483, Feb 13, 2019
Record Details
An FDA inspection of Julio Wainstein, a clinical investigator in Tel Aviv, Israel, revealed a significant failure to maintain adequate and accurate case histories. Specifically, numerous adverse events and concomitant medications for randomized subjects were not documented in source documents or final case report forms. This indicates a serious deficiency in data integrity and record-keeping practices.
View Company Profile
ID · 8c0a42a2-a864-4844-9ea3-0549a128a29f
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.